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ABSTRACT 
Intracellular pathogens are known to manipulate host cell regulatory pathways to establish an 
optimal environment for their growth and survival. Pathogens employ active mechanisms to 
hijack host cell metabolism and acquire existing nutrient and energy store. The role of the 
cellular energy sensor AMP-activated protein kinase (AMPK) in the regulation of cellular 
energy homeostasis is well documented. Here, we highlight recent advances showing the 
importance of AMPK signaling in pathogen-host interactions. Pathogens interact with AMPK 
by a variety of mechanisms aimed at reprogramming host cell metabolism to their own benefit. 
Stimulation of AMPK activity provides an efficient process to rapidly adapt pathogen 
metabolism to the major nutritional changes often encountered during the different phases of 
infection. However, inhibition of AMPK is also used by pathogens to manipulate innate host 
response, indicating that AMPK appears relevant to restriction of pathogen infection. We also 
document the effects of pharmacological AMPK modulators on pathogen proliferation and 
survival. This review illustrates intricate pathogen-AMPK interactions that may be exploited to 
the development of novel anti-pathogen therapies. 
INTRODUCTION 
Essential requirement for survival, multicellular organisms have developed a variety of 
mechanisms to recognize and eliminate invading bacterial, parasite and viral pathogens. 
Infection triggers powerful cellular signaling events, which result in a wide range of possible 
immune responses. Innate and adaptive host immunity is essential for inducing and 
maintaining an optimal immune response and protection against infection. However, in return, 
pathogens have evolved specific mechanisms to circumvent the immune response to survive 
in infected hosts. In addition, successful pathogens remodel the host cell to establish an 
optimal environment for their persistence and to reallocate resources for their replication. To 
acquire essential nutrient and energy for their own growth and proliferation, intracellular 
pathogens exploit the existing host nutrient stores and energy producingsources [1]. The 
metabolic manipulation of host cells resources is currently recognized to play an important 
role in the pathology of infection and there is growing interest in identifying the underlying 
mechanisms. Here, we detail how intracellular pathogens hijack cellular metabolism by 
suppressing or increasing the activity of the energy sensor AMP-activated protein kinase 
(AMPK). 
AMPK REGULATES CELLULAR ENERGY HOMEOSTASIS 
AMPK, A Cellular Fuel Gauge. A critical requirement for cell survival and growth is the 
maintenance of energy balance. This coordination is achieved through the function of AMPK, 
a cellular “fuel gauge” that directs metabolic adaptation to support the growth demands [2]. At 
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a critical level of signals related to impaired cellular energy status (high AMP/ATP and 
ADP/ATP ratios), occurring when cells are exposed to metabolic stress (e.g., nutrient 
deprivation, hypoxia and viral infection), AMPK functions to restore energy homeostasis by 
switching off biosynthetic pathways consuming ATP while switching on catabolic pathways 
that produce ATP. AMPK has been conserved throughout eukaryote evolution as a central 
sensor and regulator of energy homeostasis.  
AMPK Structure and Regulation. Mammalian AMPK is a heterotrimeric complex consisting 
of a catalytic (α) and two regulatory (β and γ) subunits, encoded by different genes (α1, α2, 
β1, β2, γ1, γ2, and γ3), enabling the formation of a diverse collection of αβγ heterotrimer 
combinations. AMPK is activated by binding of AMP and/or ADP to the γ-subunit, causing 
structural changes and subsequent phosphorylation of a conserved residue within the 
activation loop (Thr172) of the catalytic α subunit, which is required for AMPK activity [2]. In 
addition, another effect of AMP and ADP binding is to prevent dephosphorylation of Thr172 
and subsequent inactivation of the AMPK complex by cellular phosphatases. Furthermore, the 
binding of AMP (but not ADP) enhances AMPK activity by allosteric activation. Of note, all the 
effects of AMP and ADP are antagonized by binding of ATP, indicating that cellular AMP/ATP 
and ADP/ATP ratios primarily define the levels of AMPK activation. The major upstream 
kinase is liver kinase B1 (LKB1), a tumour suppressor mutated in Peutz–Jeghers syndrome. 
Interestingly, LKB1 appears to be constitutively active, reinforcing the importance of AMP/ 
ADP binding in the resistance of AMPK to dephosphorylation in the mechanism of AMPK 
activation. A non-canonical activation mechanism involves the phosphorylation of Thr172 by 
calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ) in response to a rise in 
intracellular Ca
2+ 
[2]. 
Downstream Effects of AMPK Activation. It is well established that AMPK represents a 
point of conversion of regulatory signals monitoring cellular energy status. In addition, recent 
evidence indicates that AMPK may also maintain cell survival through the regulation of 
processes other than metabolic pathways, such as autophagy, cytoskeletal organization, cell 
cycle and inflammation. The many proposed downstream responses to AMPK activation are 
summarized in (Fig. 1). There have been many excellent reviews recently published which 
cover the downstream effects of AMPK activation (e.g., [2, 3]). Briefly, in response to energy 
stress, activation of AMPK maintains cellular energy homeostasis by changing the balance 
between anabolism and catabolism. The overall result is the inhibition of energy-consuming 
biosynthetic pathways, such as lipid and protein synthesis, and activation of ATP-producing 
catabolic pathways, such as fatty acid oxidation, glucose uptake, and glycolysis (at least in the 
heart). AMPK regulates these pathways via acute and long term mechanisms, involving the 
phosphorylation of key enzymes and regulation of gene expression. It is important to note that 
AMPK phosphorylates acetyl CoA carboxylase (ACC), a key enzyme for fatty acid synthesis 
and oxidation. AMPK-dependent phosphorylation of ACC suppresses malonyl-CoA synthesis. 
As malonyl-CoA is both a critical precursor of biosynthesis of fatty acids and an inhibitor of 
fatty acid uptake into mitochondria via the transport system involving carnitine 
palmitoyltransferase-1, this has the dual effect of inhibiting fatty acid synthesis and enhancing 
fatty acid oxidation [4]. In complement to this metabolic switch, AMPK stimulates expression 
and translocation to the plasma membrane of glucose transporter 4 (GLUT4) through 
inhibition of HDAC5 activity and TBC1D1 and AS160, two Rab-GAP (GTPase-activating 
protein) proteins [5]. AMPK positively regulates glycolysis by phosphorylating 6-
phosphofructo-2-kinase (PFK-2) [6]. AMPK decreases protein synthesis by phosphorylating 
the tuberous sclerosis complex 1/2 (TSC1/2), an inhibitor of the mammalian target of 
rapamycin (mTOR) signaling pathway, and the regulatory associated protein of mTOR 
(raptor), and targeting the eEF2K/ eEF2 signaling pathway [7-10]. Furthermore, it has been 
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postulated that AMPK-dependent phosphorylation of PGC1α stimulates mitochondrial 
biogenesis [11]. In addition to a role in regulating metabolism, AMPK is a critical component of 
autophagy induction by phosphorylating and activating ULK1, the protein kinase that initiates 
the process [12, 13] and also through the inhibition of mTOR signaling pathway. Recent 
studies have also implicated AMPK in actin polymerization and phosphorylation of cytoskeletal 
targets [14]. 
A wide variety of AMPK agonists (i.e., AICAR and metformin) have been commonly used to 
define the downstream actions of AMPK activation (Table 1). However, several recent studies 
have reported that many of the effects of these pharmacological compounds are AMPK-
independent [15, 16] and activates AMPK indirectly through the modulation of cellular 
AMP:ATP ratio [17]. In the recent years, the use of more specific AMPK agonists that directly 
bind to the AMPK heterotrimer complex has emerged as a valuable pharmacological 
alternative to assess the physiological role of AMPK activation [18-20] (Table 1). However, it is 
highly recommended to confirm the results obtained with pharmacological AMPK activators 
with genetic knockdown/ inactivation of AMPK subunits as specific controls for activity rather 
than using the only available AMPK inhibitor, compound C, originally described as a specific 
inhibitor [21]. This compound, also known as dorsomorphin, has many AMPK-independent 
effects due to the inhibition of many other kinases with greater potency [22]. 
AMPK IN THE CONTROL OF VIRAL INFECTION 
To achieve optimal levels of proliferation and spread, viruses are dependent on a balanced 
interaction between viral and cellular proteins. Especially protein kinases are important 
regulators of virus-host interaction and many different host cell signaling pathways are 
subverted to enable the generation of the next round of infectious virions. In one hand, viruses 
turn off anti-viral and pro-apoptotic pathways, and on the other hand activate anti-apoptotic 
and pro-survival pathways. To identify host factors influencing the replication and spread of 
viruses, functional high throughput small interfering RNA (siRNA) and bioinformatics-based 
screens as well as kinome profiling approaches have been carried out and have highlighted 
the important role of the cellular protein kinase AMPK during viral infection [23-27]. Given the 
recognized role of AMPK in the control of cell metabolism, it is not surprising that this energy 
sensor appears as a specific target for virus-mediated reprogrammation of host cells. All over 
the sophisticated lifecycle of viruses, a number of temporally regulated steps have been linked 
with the suppression or increase in AMPK activation, including virus entry, expression of early 
gene products, replication, and assembly (Figs. 2A and B).  
AMPK Contribution to Virus Entry. Entry is a critical step for the initial establishment of 
infection. Internalization by macropinocytosis is the primary entry mechanism used by a 
number of viruses to enter host cells. Macropinocytosis is a well-established endocytic 
process that involves extensive actin-cytoskeletal rearrangement, leading to membrane 
ruffling and internalization of large cargo. By performing a kinome RNAi screen, in Drosophila 
cells Moser et al. found that AMPK promotes early steps of the vaccinia virus lifecycle and is 
specifically required for vaccinia-induced macropinocytic entry (Fig. 2A) [25]. The regulation of 
macropinocytosis by AMPK is achieved through metabolic-independent functions on actin 
cytoskeletal remodeling [25] and phosphorylation of key cytoskeletal targets [28-30]. 
Interestingly, the requirement of AMPK in macropinocytic events has been also reported for 
the entry of the Zaire Ebola virus in Vero (African green monkey kidney) cells [27]. These 
results raise the possibility that AMPK may act as an important component for other viruses, 
such as influenza A and African swine fever viruses, also depending on this endocytic 
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pathway to enter host cells. However, future studies investigating the contribution of AMPK in 
the entry of these viruses are warranted. 
AMPK Contribution to Virus Replication. AMPK has been identified in different high-
throughput screens as a pro-viral host factor that influence the replication of human 
cytomegalovirus (HCMV) [24, 26, 31] and vaccinia virus in a panel of human tumor cell lines 
[23]. The importance of AMPK in HCMV replication is supported by the increase of AMPK 
phosphorylation at residue Thr172 in HCMV-infected cells [24, 31]. This has been further 
confirmed by the use of AMPK inhibitor Compound C showing an antiviral action [24, 31]. 
Inhibition of AMPK attenuates the expression of early gene expression as well as viral DNA 
replication efficiency. Interestingly, the expression of the AMPK upstream kinase CaMKK is 
induced by viral infection and appears also to be an important host factor for HCMV replication 
[32]. The inhibition of CaMKK by the specific inhibitor STO-609 or the expression of a CaMKK 
kinase-dead allele inhibits the production of HCMV viral progeny. Furthermore, inhibition of 
CaMKK reduced the phosphorylation of AMPK and downstream targets during HCMV 
infection, indicating that HCMV infection requires CaMKK activity to activate AMPK [31]. 
However, the exact mechanism responsible for CaMKK activation remains unclear, but may 
potentially involve the release of endoplasmic reticulum Ca
2+ 
stores during HCMV infection 
[33]. Of note, LKB1 is probably not involved in the activation of AMPK in response to viral 
infection as this protein kinase has never been identified as hit in the siRNA kinome screens 
performed to date [24-26]. 
It has been shown that AMPK plays a major role in the interaction between avian reovirus 
(ARV) and host cells. AMPK is activated during ARV infection and contributes to maintain the 
efficiency of replication in Vero cells and transformed chicken embryo fibroblasts [34]. AMPK 
facilitates mitogen-activated protein kinase (MAPK) kinase (MKK) 3/6 - MAPK p38 signaling 
that is critical for ARV replication. The action of AMPK is independent of the inhibition of 
phosphatidylinositol 3-kinase (PI3K) or mechanistic target of rapamycin complex 1 (mTORC1) 
signaling, as wortmannin and rapamycin have no negative effects on ARV replication. 
Inhibition of AMPK by compound C causes down-regulation of MKK3/6 and MAPK p38 
phosphorylation and ARV replication, indicating that MAPK p38 is a critical downstream factor 
involved in the regulation of ARV replication. Interestingly, activation of MAPK p38 signaling 
appears to be specific to avian viruses because MAPK p38 phosphorylation is not observed 
after infection with the mammalian counterpart viruses [34].  
As an energy sensor, not surprisingly, AMPK is involved in the regulation of autophagy and 
may serve as a logical target for manipulation to enhance virus replication (Fig. 2A). Indeed, it 
is now recognized that many viruses exploit the autophagy machinery to facilitate their 
replication and survival in host cells. Autophagy is a catabolic cellular process that involves 
the degradation and turnover of damaged organelles and long-lived proteins after forming a 
cytoplasmic double-membrane vesicle or autophagosome. Activation of autophagy during 
nutrient starvation is a way to provide a limited amount of nutrients for the survival of cells. 
Thus, many viruses have evolved mechanisms to promote autophagy to support the high 
energy cost of replication. Some viruses (mainly positive stranded RNA viruses) use the 
autophagy machinery to hide their RNA replication intermediate into the cytoplasmic vesicles. 
However, autophagy can also destroy cytosolic pathogens by targeting viral components to 
degradation through lysosomes, in a process called xenophagy. While the evasion of 
autophagy by pathogens has been demonstrated, recent work suggests that some viruses 
require components of the autophagic machinery to benefit their replication and is therefore a 
critical process in viral pathogenesis [35]. Recent evidence have showed that dengue virus 
(DENV) induces autophagy to degrade lipid droplets (lipophagy) and release free fatty acids 
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required for efficient virus replication in human hepatoma cell lines [36]. This concept is further 
supported by the rescue of DENV infection by addition of exogenous fatty acid when 
autophagy is inhibited [36]. Interestingly, some viruses encode autophagy-promoting proteins 
to induce autophagy. Simian virus 40 (SV40) small T antigen activates AMPK through the 
inactivation of protein phosphatase 2A (PP2A) which results in the inactivation of mTOR and 
induction of autophagy for survival during glucose deprivation of cancer cells [37]. Similarly, 
the nonstructural protein p17 of ARV functions as a positive regulator of autophagy by 
activating AMPK Vero cells and transformed chicken embryo fibroblasts [38]. Another 
example is the capsid protein from porcine circovirus type 2 (PCV2) that induces 
autophagosome formation and enhances autophagic flux by increasing AMPK 
phosphorylation with a concomitant inhibition of mTOR signaling in porcine kidney cells [39]. 
In the context of the human immunodeficiency virus (HIV-1) infection, inhibition of autophagy 
reduces viral replication. Although in this model the role of AMPK has not yet been explored, it 
is interesting to note that infection of CD4+ T cells is associated with a mitochondrial 
depolarization and ATP loss, concomitantly with the activation of the autophagy pathway [40]. 
Thus, AMPK could be involved in the regulation of HIV replication. 
AMPK-mediated Coordination of Cellular Metabolism. During Viral Infection a growing 
body of evidence implicates a key role for metabolic function during viral infection and recent 
studies have reported that viruses target the host cell metabolic machinery to favor their 
propagation. For instance, upon infection, HCMV takes control of numerous cellular processes 
and reprograms the metabolic activity of the host cell by increasing glucose uptake through 
the increase of glucose transporter GLUT4 levels at the plasma membrane [32, 41]. 
Consistent with the role of AMPK in the modulation of key glycolytic enzymes, including 
glucose transporters (Glut1 and Glut4), hexokinase, and phosphofructokinase-2 (PFK-2), to 
increase glycolytic flux [2], AMPK has been linked to a substantial subset of metabolic 
changes induced during HCMV infection in human fibroblasts [26, 31]. By stimulating glucose 
uptake, AMPK provides fuel for glycolysis and the TCA cycle. These results demonstrate that 
AMPK is required to create a favorable metabolic environment for HCMV replication by 
phosphorylating multiple substrates that switch on catabolic pathways producing ATP. 
However, AMPK activation also induces the phosphorylation of substrates that block ATP-
consuming anabolic pathways, such as fatty acid and protein synthesis, disfavoring viral 
replication [42]. The substrates of AMPK are ACC, playing a key role in the synthesis and 
metabolism of fatty acids, and the tuberous sclerosis protein complex TSC1/2, which 
negatively regulates translation through inhibition of mTOR [2]. Thus, HCMV-induced 
activation of AMPK would be detrimental to infection by inhibition of both fatty acid synthesis 
and protein translation. To resolve this paradigm, HCMV uncouples the catabolic and anabolic 
regulation by AMPK. An HCMV-encoded protein (pUL38) binds to the TSC1/2 complex and 
prevents the inactivation of mTOR signaling by activated AMPK in human foreskin fibroblasts 
[43, 44]. Although mTOR is an essential component of protein translation in the productive 
viral growth cycle, it is also required for HCMV-mediated induction of ACC expression and 
activation of fatty acid synthesis through the proteolytic processing of sterol regulatory 
element-binding protein 1c (SREBP1c) [42]. HCMV also exploits host defense mechanisms to 
increase lipogenesis in infected cells. Upon infection, HCMV induces the expression of 
interferon-inducible host protein, viperin [45]. Interaction with the viral mitochondrial inhibitor of 
apoptosis (vMIA) relocalizes viperin to the mitochondria where it inhibits β-oxidation as shown 
in human fibroblasts [45]. This results in reduced cellular ATP levels and activation of AMPK. 
In turn, AMPK activation induces GLUT4 expression, stimulates glucose uptake and increases 
glycolytic flux in infected cells. Increase in intracellular glucose, in addition to the induction of 
glycolysis, leads to the enhanced transcription of genes encoding lipogenic enzymes through 
the translocation to the nucleus of the glucose-regulated transcription factor carbohydrate 
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response element-binding protein (ChREBP) [46]. These data indicates that viperin is a major 
effector in the remodeling of host cell lipid metabolism during infection, facilitating the 
formation of HCMV membrane envelope. 
During the course of infection, herpes simplex virus type 1 (HSV-1) differentially regulates the 
activity of AMPK for its propagation and survival in primary cortical neurons [47]. At early 
times post infection, HSV-1 downregulates AMPK phosphorylation but this inhibition is 
gradually reversed during the course of infection. Initial inhibition of AMPK would be beneficial 
for the synthesis of viral proteins and lipids, as AMPK activation inhibits protein translation and 
lipid synthesis [2]. At later times point, AMPK activation represents a strategy to counteract 
antiviral host mechanism (e.g., induction of apoptosis) and to hijack the cellular metabolic 
pathways to maintain cellular energy status and establish latency in infected cells [47]. The 
effects of AMPK are carried out through the modulation of cellular NAD+ levels and activation 
of sirtuin 1 (SIRT1), a NAD+ dependent histone deacetylase, interfering with the p53-
dependent pro-apoptotic response and metabolic pathways. SIRT1 and AMPK are known to 
both regulate each other and share similar effects on diverse processes such as cellular fuel 
metabolism and mitochondrial function [48]. On one hand, AMPK can function as a SIRT1 
activator by increasing the cellular NAD+/NADH ratio via transcription of the NAD+ 
biosynthetic enzyme nicotinamide phosphoribosyltransferase (Nampt), converting 
nicotinamide into NAD+, leading to SIRT1 activation. On other hand, SIRT1 modulation of the 
acetylation status of LKB1 is involved in the activation of AMPK, consistent with the concept 
that AMPK and SIRT1 are components of a cycle. During HSV-1 infection, activation of the 
AMPK/SIRT1 pathway contributes to the metabolic homeostasis of cell host by activation of 
peroxisome proliferator-activated receptor γ co-activator-1α (PGC1α), a master regulator of 
mitochondrial biogenesis [47]. 
AMPK In Innate Antiviral Response. Recent discoveries have revealed a critical relationship 
between innate immune response to pathogens and cellular metabolic sensing pathways to 
confer an efficient defense against infection [49]. Emerging evidence indicate that AMPK have 
intrinsic innate immune functions and restricts the replication of viruses (Fig. 2B). Moser et 
al.showed evidence that AMPK activation with Rift Valley fever virus (RVFV) infection restricts 
its replication by blocking fatty acid synthesis through ACC phosphorylation in mouse 
embryonic fibroblasts [50]. This was further supported by the rescue of AMPK-mediated RVFV 
restriction by pre-treatment with palmitate, the first product of fatty acid synthesis. Inhibition of 
AMPK by compound C significantly increased RVFV infection but treatment with the mTORC1 
inhibitor rapamycin showed no significant difference in RVFV infection, indicating that 
mTORC1 signaling is not required for the antiviral activity of AMPK. Activation of AMPK is 
dependent on the upstream AMPK kinase LKB1, and is triggered by incoming particles but not 
viral replication. Inhibition of the alternative upstream kinase CaMKK by STO-609 had no 
effect on infection level. Additionally, AMPK and LKB1 also appears to act as intrinsic immune 
components to inhibit viral replication of multiple arboviruses, including flavivirus kunjin virus 
(KUNV), togavirus sindbis virus (SINV), and rhabdovirus vesicular stomatitis virus (VSV) [50]. 
These results indicate that LKB1/AMPK signaling represents a potential pharmacological 
target to limit viral replication, at least for viruses known to have important lipid dependencies. 
Interestingly, RFVF and KUNV infection was significantly decreased in the presence of the 
direct AMPK activator A-769662 in a dose-dependent manner (Table 1). 
Since AMPK acts as a restriction factor for virus replication, mainly by inhibiting host catabolic 
and biosynthetic activities, viruses have evolved mechanisms of evasion to limit AMPK activity 
during the course of infection (Fig. 2B). Different mechanisms for repression of AMPK 
signaling have been reported. Hepatitis C virus (HCV)-encoded NS5A protein has been 
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shown to down-regulate AMPK activation by inhibiting AMPK Thr172 phosphorylation in 
human hepatoma cell lines [51]. HCV infection activates the protein kinase B (PKB)/ (AKT) 
pathway to phosphorylate AMPK at Ser485, resulting in the inhibition of AMPK activation. The 
importance of Ser485 phosphorylation for HCV genome replication of Ser485 was confirmed 
by over-expression of a non phosphorylable mutant (S485A) [51]. This mechanism of AMPK 
inhibition may be shared with HMCV during the early time points post-infection where 
expression of immediate early proteins is associated with increased PKB/AKT activation [43, 
52]. Similarly, it has been shown that PKB/AKT antagonizes AMPK activation by increasing 
AMPK Ser485 phosphorylation in ischemic heart in response to insulin [53]. Reduced AMPK 
activity during HCV infection permits the synthesis of lipids at high levels, which are required 
for virus replication. Conversely, activation of AMPK with pharmacological agonists (Table 1) 
abrogates lipid accumulation and reduced HCV replication [51]. To promote proliferation and 
transformation, the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) 
oncogenic protein inhibits the activity of AMPK through the phosphorylation of LKB1 at Ser325 
and Ser428 mediated by the ERK-MAPK signaling pathway in human nasopharyngeal 
epithelial cells [54]. By altering the cellular redox state (decreased NAD+levels), the HIV-1-
encoded Tat protein inhibits the activity of host NAD+ dependent histone deacetylase SIRT1 
leading to decreased AMPK activity in HeLa cell line that expresses high levels of CD4 [55]. In 
this context, the inhibition of the SIRT1/AMPK cellular checkpoint is associated with increased 
Tat-induced HIV-1 LTR transcription and enhanced HIV-1 replication [55]. Inhibition of HIV-1 
transcription transactivation may be related to the SIRT1-mediated deacetylation of Tat [56] 
because Tat transcriptional activity is dependent on cellular acetylation by targeting cellular 
histone acetyltransferases [57]. However, the role of AMPK appears more complex. Indeed, 
AMPK activation was found to coordinate the reactivation of latent HIV-1 proviruses process 
via protein kinase C (PKC) signaling [58]. Therefore these results suggest that AMPK has 
differential roles during HIV-1 lifecycle. 
Antiviral Therapeutics Opportunities. Given the importance of virus-host interaction in 
controlling the different steps of viral infection, drugs targeting host proteins are of attractive 
therapeutic potential. Manipulation of the energy sensor AMPK has emerged as a promising 
antiviral strategy. In (Table 1) are listed pharmacological compounds with significant antiviral 
activity acting either through the activation or inhibition of AMPK signaling. Notably, 
cannabinoid 1 (CB1) antagonist AM251 shows effective antiviral effects against HCV in 
human hepatoma cells [59]. These effects are, at least in part, due to the inhibition of 
lipogenesis mediated by activation of AMPK. This is consistent with previous results obtained 
with the AMPK agonists 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), 
metformin and A-769662 on the inhibition of HCV replication by decreasing lipid accumulation 
[51] (Table 1). In addition, the use of AMPK agonist AICAR has been reported to protect mice 
from the deleterious effect of influenza infection [60]. 
AMPK activation was shown to be a crucial component in the inhibitory effect of Tanshinone II 
A (a lipid-soluble monomer extracted from the root of Salvia miltiorrhiza) on Tat-induced HIV-1 
LTR transactivation in a HeLa-derived cell line expressing surface CD4, CXCR4, CCR5, and 
containing a chromatin-integrated HIV-1 LTR [61]. Tanshinone II A plays an important role in 
the regulation of cellular redox balance during HIV-1 infection and can revert Tat-induced 
inhibition of SIRT1 activity. These effects are mediated by redox-regulated Nampt activity and 
modulation of Nampt through activation of AMPK [61]. Thus, targeting redox signaling 
emerges as a novel therapeutic strategy to fight against HIV-1 infection and may lead to the 
development of new class of drug with potential antiviral activity. 
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BACTERIAL INFECTION AND AMPK 
Control of Bacterial Infection by Xenophagy. Recent evidence demonstrates that 
autophagy, best known as a mechanism for surviving starvation, is now considered as a 
critical arm of the host defense against intracellular bacterial pathogens. This selective 
autophagic destruction of intracellular pathogens, also known as xenophagy, plays a critical 
role in innate immune response to bacterial invasion [62]. Several pathways critical for the 
specific control of xenophagy have been identified. Recently, AMPK has emerged as a 
potential key player in the signaling pathways that contribute to the induction of autophagy 
during infection (Fig. 3). It has been reported that infection of intestinal epithelial cells by 
enterotoxigenic Escherichia coli (ETEC) induces autophagy through activation of AMPK [63]. 
Induction of autophagy may serve as a host defense against infection because inhibition of 
autophagy resulted in decreased survival of infected cells. In addition, Toll-like receptor (TLR) 
stimulation by the lipoprotein LpqH from Mycobacterium tuberculosis (Mtb) was found to 
activate antibacterial autophagy through increases in intracellular calcium following AMPK 
activation in human primary monocytes [64]. Consistently, siRNA-mediated knockdown of 
CaMKK-β and AMPK significantly abrogated LpqH-induced autophagy. Another important 
upstream signal triggering xenophagy defense pathway is host membrane damage (e.g., by 
bacterial toxins) [65, 66]. Indeed, damages of the plasma membrane are known to cause 
cellular amino acids starvation and energy shortage, the classic inducers of autophagy. 
Various bacterial pore-forming toxins (PFT), including α-hemolysin from Staphilococcus 
aureus and cytolysin from Vibrio cholerae, have been demonstrated to activate AMPK by 
causing a massive, but transient drop of intracellular ATP in a non-virally transformed human 
keratinocyte cell line [65]. In turn, AMPK activation leads to the deactivation of mTORC1 
signaling. HeLa cells infected with Shigella flexneri triggers a rapid induction of an intracellular 
amino acid starvation, which leads to the deactivation of mTOR signaling and induction of 
autophagy [66]. 
The importance of this innate immune defense mechanism has been highlighted by the 
identification of bacterial strategies that were evolved to escape from degradation mediated by 
autophagy. Salmonella typhimurium escapes this defense pathway by the recruitment and 
reactivation of mTOR at the surface of the Salmonella-containing vacuole in infected HeLa 
cells [66]. Pseudomonas entomophila paralyzes the global host response to infection in gut 
Drosophila by causing a severe reduction in protein synthesis, thereby inhibiting immune and 
repair gene programs [67]. After ingestion of bacteria, the severity of cellular damages 
induced by monalysin, a P. entomophila PFT, and microbicidal reactive oxygen species (ROS) 
production in the Drosophila gut induces an excessive and detrimental stress response that 
ultimately disrupts gut integrity. Interestingly, reduction in AMPK activity partially restored host 
translation in P. entomophila infected flies and makes flies more resistant to P. entomophila 
infection, indicating that activation of AMPK by monalysin and ROS production plays a 
detrimental role in the pathogenesis [67]. 
Antibacterial Therapeutics Opportunities. The increasing prevalence of drug-resistant 
bacteria has stimulated the development of host-directed therapies to amplify endogenous 
effector mechanisms. It is now clear that autophagy is associated with innate immune 
response and contributes to antibacterial defense during infection. Thus, autophagy is an 
attractive candidate. Interestingly, AMPK-activating drugs have already demonstrated 
beneficial outcomes on antimicrobial responses (Fig. 3). It has been established that AICAR 
promotes antibacterial autophagy against Mtb infection in murine bone marrow-derived 
macrophages (Table 1), in part through the induction of PGC1α and subsequent 
transcriptional upregulation of mitochondrial biogenesis and autophagy-associated genes [68]. 
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AICAR-induced autophagy activation is mediated through the down-regulation of mTOR 
signaling and the phosphorylation of ULK1, the upstream kinase of autophagy machinery. In 
addition, another AMPK activator, the oral anti-diabetic biguanide metformin has been recently 
shown to control the growth of Mtb in infected mice by improving the immune response [69]. 
The effects of metformin were abolished in human monocyte-derived macrophages where 
AMPK is knocked-down or inhibited chemically. The protective effect of metformin is mediated 
by its cellular innate antimicrobicidal functions and increased acidification of mycobacterial 
phagosome. Metformin-mediated inhibition of mitochondrial complex I (NADH-
dehydrogenase) activity is known to induce the production of mitochondrial ROS [70]. 
Importantly, metformin therapy has been associated with beneficial clinical outcomes in 
patients infected with Mtb [69]. Furthermore, metformin enhances the efficacy of conventional 
anti-Mtb drugs, indicating that this drug can be use as adjuvant therapy to improve the 
effective treatment of Mtb infection. 
 
INTERACTION BETWEEN AMPK AND PARASITES 
Like bacteria or viruses, parasites manipulate host cells to establishment a successful 
infection after parasite entrance. Once inside the host, intracellular or extracellular parasites 
must negotiate their surrounding nutritional and signaling environment to obtain energy and 
biosynthetic precursors that support their survival and high growth rate. At this level a nutrient 
competition is established between the manipulative parasite trying to obtain usable energy 
and metabolites and the host attempting to sequester the same precursors from the pathogen. 
Moreover, some parasites are auxotrophic for several metabolites being the host the only 
viable source for acquisition. The balance between these mechanisms becomes crucial for the 
parasite survival. In the core of this metabolic network, AMPK has emerged as a potential 
candidate modulated by parasites due to its crucial role on key metabolic pathways. 
AMPK on the Core of Host-parasite Metabolic Coupling. Metabolic manipulation of host 
metabolism is regularly identified as required for intracellular pathogen growth. Recent studies 
with Toxoplasma gondii [71], Trypanosoma brucei [72], Leishmania spp [73, 74], Schistosoma 
mansoni [72] and Plasmodium berghei [75] have paved the way to our understanding on the 
molecular mechanisms used by parasites to take advantage of the nutritive host resources. 
Nevertheless, the role of AMPK during the metabolic host-parasite crosstalk remains largely 
unexplored.  
Caradonna et al. by employing a genome-wide RNA interference screen, targeting host genes 
in HeLa cells infected with Trypanosoma cruzi for the identification of cellular processes that 
fuel parasite growth showed that sustained AKT-mTORC1 pathway regulates intracellular T. 
cruzi growth [76]. The maintenance of high cellular ATP/ADP ratios at higher levels provided a 
distinct advantage for the parasite, which therefore kept AMPK activity in check. Thus, acute 
silencing of AMPK catalytic (PRKAA1) or the regulatory subunit (PRKAB1) provides a more 
favorable growth environment for intracellular T. cruzi. Although so far it has not been 
confirmed in vivo, AMPK inhibition is suggested to contribute for T. cruzi survival. Recently we 
demonstrated that AMPK is in contrary crucial for the establishment of a microenvironment 
more prone to L. infantum survival in macrophages [73]. Previous analysis on the 
transcriptomic signature of L. major infected macrophages has revealed that carbohydrate 
and lipid metabolism were among the most altered pathways during infection. Increased 
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mRNA levels of glucose transporters as well as key glycolytic enzymes encoding genes, such 
as hexokinases (Hk), pyruvate kinase M2 (Pkm2) and lactate dehydrogenase a (Ldha) were 
induced in the presence of live but not heat-killed L. major promastigotes. L. major also 
induced a down-regulation of a number of genes implicated in the tricarboxylic acid (TCA) 
cycle and oxidative phosphorylation suggesting that infected macrophages mainly rely on 
increased glycolytic flow for energy production. On the other hand, L. major led to cholesterol 
and triglycerides accumulation on infected macrophages by enhancing the expression of 
scavenger receptors involved in the uptake of Low-Density Lipoprotein (LDL), inhibiting 
cholesterol efflux and increasing the synthesis of triacylglycerides [74]. The accumulation of 
lipid droplets in close proximity to parasitophorous vacuoles advocates the former structure as 
a potential high-energy substrate source for the intracellular parasite. We observed that 
following L. infantum infection, macrophages switch from an early glycolytic to an oxidative 
metabolism, in a process requiring SIRT1 and LKB1/AMPK. In the absence of SIRT1 or LKB1, 
infected macrophages are not able to induce AMPK activation leading to an impairment of the 
metabolic switch. In that sense, the AICAR-induced AMPK activation contributes to parasite 
survival while inhibition of AMPK using compound C resulted in lower parasite numbers in 
vitro. Interestingly we demonstrated that AMPK inactivation specifically in the myeloid 
population led to a reduced L. infantum burden in vivo [73]. Gastrointestinal nematodes also 
affects profoundly host metabolism. The infection of CD11c-specific AMPKα
-/-
 (DC-AMPK
-/-
) 
mice with the hookworm Nippostrongylus braziliensis led to a dysregulation of Th2 immune 
response concomitantly with a failure to regenerate tissue damage mediated by pathogen. 
Deregulated responses generated in DC-AMPK
-/- 
mice were associated with increased Type-1 
responses, greater numbers of Th17 cells, and defects in the generation of alternatively 
activated macrophages. Therefore, AMPK activity in myeloid cells was shown to regulate host 
protection against GI parasites [77]. Although still insufficient, these examples highlight the 
strategies used by the parasites to explore host resources shedding some light on cellular 
metabolic subversion mechanisms induced by microbe infections within the host. In this 
context, the modulation of AMPK activity has been put forward as a possible therapeutic 
target against parasitic diseases. 
Conservation of the AMPK Machinery in Parasite. With the exception of the 
Encephalitozoon cuniculi obligate intracellular parasite, which lack of an identifiable AMPK 
and presumably relies on host cell AMPK to regulate energy balance [78], several members of 
this highly conserved kinase family were already described in yeasts and plants, named 
sucrose non-fermenting 1 (SNF1) and SNF1-related protein kinase 1 (SnRK1), respectively 
[79, 80]. SNF1 and SnRK1 homologs develop similar functions in what concerns the 
surveillance of the metabolic status in response to nutrient and environmental stress through 
the induction of catabolic processes and a general repression of anabolism. Similarly to these 
organisms, some reports have defined the presence of AMPK related proteins in eukaryote 
parasites. A systematic functional analysis of protein kinases of Plasmodium berghei identified 
a homolog of SNF1 described as SNF1/KIN. This protein was shown to be important for 
sporozoite development, particularly in the egression to the salivary gland of the mosquito 
Anopheles stephensi by acting as a regulator of energy metabolism [81]. Similarly, a PfKIN 
gene was identified in P. falciparum where it is predominantly expressed in the gametocyte 
stage being involved in the transmission and adaptation of the malaria parasite from the 
human bloodstream to the mosquito midgut [82]. A comparative analysis of the kinomes of 
representative members of pathogenic trypanosomatids, namely Trypanosoma brucei, 
Trypanosoma cruzi and Leishmania major have highlighted that AMPK homologues are 
relatively poorly represented within trypanosomatid genomes as compared to humans, 
although are predicted to be active [83]. The procyclic forms of T. brucei monitor changes in 
glucose levels to regulate surface molecule expression, which is important for survival in the 
 Version: Postprint (identical content as published paper) This is a self-archived document from i3S – Instituto de 
Investigação e Inovação em Saúde in the University of Porto Open Repository For Open Access to more of our 
publications, please visit http://repositorio-aberto.up.pt/  
 
A
0
1
/0
0
 
tsetse fly vector. While the αAMPK subunit remains elusive, the β and γ subunits (TbAMPKβ 
and TbAMPKγ, respectively) play a role in surface molecule expression, as silencing of the 
genes leads to upregulation of procyclin expression. Moreover, the localization of the scaffold 
(β) subunit suggests positioning in the cell consistent with a role as an intermediary between 
surface molecule expression and glycolysis providing thus a molecular connection between 
these two mechanisms [84]. Finally, a SNF1 type protein kinase gene from Toxoplasma gondii 
(TOXPK1) with 58% identity to human AMPKα was shown to be transiently expressed to up-
regulate glycogen biosynthesis during the development of tachyzoites into bradyzoites [85, 
86]. Although efforts were made to characterize AMPK homologs in parasite organisms, their 
role during parasite adaptation to host remains elusive. 
CONCLUSION AND PERSPECTIVES 
It is now clear that pathogens have evolved multiple mechanisms to manipulate host 
regulatory pathways and hijack host cell metabolism to their own benefit. Modulation of AMPK 
activity appears to be a fundamental process involved in pathogen-host interaction. Although 
activation of AMPK helps pathogens to obtain sufficient amounts of energy and nutrient for 
their replication, inhibition of AMPK is also a strategy used by pathogens to evade innate host 
defense. This intricate pathogen-AMPK interaction is not limited to mammalian systems and 
seems to be conserved through evolution. Recent data suggest the existence of plant-specific 
SnRK1 (SNF1-related protein kinase) trimeric complexes involved in plant-pathogen 
interactions [87]. The SnRK1 heterotrimeric complex containing AKINβγ could be implicated in 
plant pathogen resistance through the interaction in the cytoplasm with AtHSPRO1/2 proteins, 
two defense-related genes, putatively involved in plant defense response [87]. In further 
support of this role, the expression of an antisense SNF1 transgene in Nicotiana benthamiana 
plants causes enhanced susceptibility similar to that conditioned by the geminivirus AL2 and 
L2 transgenes, whereas SNF1 overexpression leads to enhanced resistance. These 
observations suggest that the metabolic alterations mediated by SNF1 are a component of 
innate antiviral defenses and that SNF1 inactivation by AL2 and L2 is a counter-defensive 
measure [88]. 
Determining how intracellular pathogens manipulate host metabolic functions to support their 
own growth and survival is essential to identify mechanisms of pathogenicity and host 
adaptation. Blocking or activating specific metabolic pathways may improve host cells 
response to intracellular pathogens and could be used in the treatment of infectious diseases. 
Exciting translational opportunities are arising from the use of pharmacological AMPK 
agonists/ antagonists (Table 1) and could pave the way towards the design of novel host-
directed therapies. Thus, a major future challenge will be to dissect the precise role that 
AMPK plays in the life cycle of viruses, bacteria and parasites, allowing a better rationale to 
identify new targets and design novel anti-pathogen clinical interventions. 
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Figure 1. Target proteins and pathways regulated by AMPK. Main catabolic and anabolic pathways activated and 
inhibited, respectively, by AMPK activation are depicted. The proteins that are likely to mediate the effects of AMPK 
are shown (Direct AMPK targets are labeled with a phosphorylation mark). ACC, acetyl CoA carboxylase; AMPK, 
AMP-activated protein kinase; CaMKKβ, calcium/calmodulin-dependent protein kinase kinase β; ChREBP, 
carbohydrate response element-binding protein; FAT/CD36, fatty acid translocase/cluster of differentiation; HDAC5, 
histone deacetylase 5; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; LKB1, liver kinase B1; PFK2, 6-
phosphofructokinase 2; PGC1α, peroxisome proliferator-activated receptor γ co-activator-1α; SREBP1c, sterol 
regulatory element binding protein TCB1D1/4, Tre-2/BUB2/cdc 1 domain 1/4; TSC2, Tuberous sclerosis 2; ULK1, 
Unc-51-like kinase 1. 
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Figure 2. Viral infection mediates a differential regulation of AMPK signaling pathway. During infection, manipulation 
of host AMPK activity is essential in the establishment and/or maintenance of infection. Virus infection may result in 
the stimulation (A) or inhibition (B) of AMPK to support virus growth and replication. AMPK, AMP-activated protein 
kinase; CaMKKβ, calcium/calmodulin-dependent protein kinase kinase β; GLUT4, glucose transporter 4; Nampt, 
nicotinamide phosphoribosyltransferase; MKK3/6, MAPK kinase 3/6; mTORC1, mechanistic target of rapamycin 
complex 1; LKB1, liver kinase B1; LMP1, latent membrane protein 1; NS5A, viral nonstructural protein 5A; p38 
MAPK, p38 mitogen-activated protein kinase; SIRT1, Sirtuin 1; TSC2, Tuberous sclerosis 2; ULK1, Unc-51-like 
kinase 1. 
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Figure 3. AMPK in innate host response to bacterial infection. AMPK acts as a restriction factor targeting bacteria to 
xenophagy. AMPK activation by the drugs AICAR and metformin induces antibacterial autophagy. AICAR, 5- 
aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, AMPK, AMP-activated protein kinase; CaMKKβ, 
calcium/calmodulin-dependent protein kinase kinase β; mTORC1, mechanistic target of rapamycin complex 1; 
PGC1α, peroxisome proliferator-activated receptor γ co-activator-1α; ULK1,  Unc-51-like kinase 1. 
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Table 1. Drugs acting through AMPK signaling to restrict intracellular pathogens survival and proliferation 
